Status:
UNKNOWN
Gabapentin Oral Solution in Decreasing Desflurane Associated Emergence Agitation
Lead Sponsor:
Kuwait Specialized Eye Center
Conditions:
Emergence Agitation After Desflurane Anesthesia
Eligibility:
All Genders
2-6 years
Phase:
NA
Brief Summary
to study the effect of oral gabapentin (5 mg/kg) on emergence agitation after desflurane anesthesia in pediatrics undergoing starbismus surgery
Eligibility Criteria
Inclusion
- pediatric patients (2-6 years old), with an American society of Anesthegiologists physical status (ASA) I-II who were undergoing strabismus surgery (for more than one muscle)
Exclusion
- failure to obtain consent, mental retardation or developmental delay, epilepsy, psychiatric or neurological diseases that impair communication, current use of gabapentin, psychotropic or opioids.
Key Trial Info
Start Date :
January 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2017
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03347916
Start Date
January 5 2017
End Date
November 30 2017
Last Update
November 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kuwait Specialized Eye Center
Kuwait City, Kuwait, 113111